First messenger RNA influenza vaccine outperforms standard-dose vaccination
1. mFlusiva is the first messenger RNA influenza vaccine approved in the United States, with the FLUENT phase 3 trial ...
Tag: Influenza vaccine
2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome
mFlusiva outperforms standard-dose flu vaccine in adults 50 and older The U.S. Food and Drug Administration (FDA) approved mFlusiva (mRNA-1010) ...
mFlusiva becomes the first mRNA influenza vaccine approved by the FDA
1. The FLUENT trial demonstrated 26.6% relative vaccine efficacy over a standard-dose comparator in adults 50 and older, clearing the ...
Concomitant COVID-19 and influenza vaccination not linked to increased adverse events
1. In this target trial emulation, same-day administration of COVID-19 and influenza vaccines was not associated with an increased risk ...
2 Minute Medicine Rewind May 11, 2026
Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults 1. Adjuvanted influenza vaccines did not differ significantly in effectiveness compared ...
Influenza vaccination improves survival and reduces readmissions in patients hospitalized for acute heart failure
1. All-cause mortality and hospital readmissions were significantly decreased with influenza vaccination compared to usual care. 2. Significantly fewer adverse ...
Maternal influenza vaccine during pregnancy not linked to adverse early childhood outcomes
1. Over a mean follow-up period of 3.6 years, no significant association was detected between maternal influenza vaccination during pregnancy ...
Influenza vaccine administered to all pediatric emergency department patients may be cost-effective
1. In this cost-effectiveness analysis, offering influenza vaccination to all eligible patients in the pediatric emergency department (PED) provided the ...
Older adults receiving recombinant influenza vaccine better protected against influenza
1. Older adults receiving recombinant influenza vaccine experienced fewer cases of polymerase chain reaction (PCR) confirmed influenza-like illness than patients ...
Influenza vaccination in children decreases risk of death
1. Estimated influenza vaccine effectiveness (VE) was 65% against laboratory-confirmed influenza-associated deaths among children. 2. Vaccine effectiveness was lower at ...
